Moderna got the FDA to change its mind and review its flu vaccine after some concessions


Moderna’s stock was surging after the FDA said it would review the biotech’s flu-vaccine candidate, a week after it had refused to do so.

You May Also Like

UK carbon price falls to record low

The cost of UK carbon emissions permits has fallen to an all-time…

Is it fair that my ex-husband’s greedy wife inherits part of his parents’ $1 million fortune?

“Do I have any grounds to sue for part of the inheritance?”

Here’s how much money Heisman Trophy finalists Mendoza, Pavia and Love made from NIL deals this season

The Heisman Trophy award may not come with a cash prize, but…

Robinhood misses out on the S&P 500 yet again, with Trade Desk to soon join the index

Trade Desk’s stock is soaring, with the ad-tech company set to replace…